US Launches Tariff Probe Against Germany Over Drug Pricing Policies

The United States has initiated a Section 301 tariff investigation into Germany's drug pricing policies. This move targets what the U.S. considers unfair practices affecting pharmaceutical costs.

19 Jun, 03:04 — 19 Jun, 03:04

Post Share

Sources

Showing 1 of 2 sources

bloombergHigh4d ago

US Starts Section 301 Probe of Germany Over Pharmaceuticals - Bloomberg.com

US Starts Section 301 Probe of Germany Over Pharmaceuticals Bloomberg.com

Read full article →

Coverage Timeline

First report: bloomberg · 19 Jun, 03:04|Full coverage: 2 · 6h|Window: 6h

Left-leaningCenterRight-leaning

bloomberg19 Jun, 03:04First to report

US Starts Section 301 Probe of Germany Over Pharmaceuticals - Bloomberg.com

6h later

cnbc19 Jun, 08:50Latest update

PERSPECTA

PERSPECTA

US Launches Tariff Probe Against Germany Over Drug Pricing Policies

Sources

US Starts Section 301 Probe of Germany Over Pharmaceuticals - Bloomberg.com

Coverage Timeline

US Starts Section 301 Probe of Germany Over Pharmaceuticals - Bloomberg.com

U.S. opens tariff probe targeting Germany’s drug pricing policies

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Significant Oil Price Rollback Announced

Latvijas Finieris Plans Major Development with €400 Million Investment

South Korea Considers Raising Departure Levy to Boost Tourism Fund

PERSPECTA